Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol versus ondansetron for prevention of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy
IRCT20221108056438N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Haloperidol arm with Ondansetron arm (2 arms). Primary endpoint: Nausea and vomiting. Started Dec 2022; status: completed.
02
Drugs
haloperidolondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20221108056438N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056438N1.